Elon Musk's Assault on the Government Has Canceled a Human Trial for a Promising HIV VaccineElon Musk's criticism of USAID funding cuts has halted critical HIV vaccine research in Africa.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ NationLenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
Beginning of end of HIV epidemic? - Harvard GazetteResearchers are cautiously optimistic about a new preventative treatment for the AIDS virus, lenacapavir, showing promising results in preventing infection.
Trial shows that shot taken twice a year very effective at preventing HIV in women - LGBTQ NationLenacapavir injections taken twice yearly show 100% efficacy in preventing HIV infections in women and girls.
Beginning of end of HIV epidemic? - Harvard GazetteResearchers are cautiously optimistic about a new preventative treatment for the AIDS virus, lenacapavir, showing promising results in preventing infection.
Vaccine-o-licious Drag Pageant Raises Awareness for HIV ResearchThe 19th Annual Vaccine-O-Licious event in Brooklyn focused on encouraging attendees to register to vote, featured a drag competition, and promoted community awareness about essential HIV research.